| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |